Development

Articles

A coalition establishes a secure, direct link between a physical tablet and a digital backend for supply chain integrity.

Study Demonstrates Digitalization of Tablets

The divestment of the pharma and food ingredients business is in line with Ferrer’s new strategy to focus on the core business of branded pharmaceuticals.

Riverside Acquires Pharma and Food Ingredients Biz from Ferrer

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

The key is to ensure that excipients only interact with APIs via desired mechanisms.

Managing Excipient Interactions

A new sucrose product from MilliporeSigma has reduced nanoparticle impurities.

Low-Impurity Sucrose Lowers Risk of Protein Instability in Biopharmaceutical Formulation

On Tuesday Nov. 5, 2019, Dr. Meinolf Brackhagen from DuPont Nutrition & Biosciences will discuss the current and future roles of excipient suppliers

Exploring the Role of Excipient Suppliers

Frank Romanski, PhD is head of Global Marketing, Pharma Solutions, BASF Corp, Florham Park, NJ, frank.romanski@basf.com.

High-throughput platforms can be used to develop tertiary phase diagrams, which can be leveraged to identify the most stable SEDDS formulations and excipients for lipid-based drug delivery systems.

How Excipient Type Influences Self-Emulsifying Drug Delivery

George Collins is vice president, Vanderbilt Chemicals LLC. 

Katherine Ulman is president, KLU Consulting.

Douglas G. Muse is consultant—Compendial Affairs, Eli Lilly & Co.

Joseph Zeleznik is chair, IPEC-Americas QbD Committee

Priscilla Zawislak is global regulatory affairs advocacy manager, DuPont Nutrition & Biosciences

Elizabeth Tocce is associate application development engineer, Dupont.

R. Christian Moreton, PhD, is vice-president of pharmaceutical sciences at Finnbrit Consulting and a member of Pharmaceutical Technology’s editorial advisory board.

This article seeks to encourage continued dialogue among stakeholders to achieve consensus regarding excipient additives and processing aids.

Additives and Processing Aids in Pharmaceutical Excipients

Colorcon Ventures looks to fund promising startups in drug manufacturing, delivery, and supply chain.

Colorcon Launches $50 Million Venture Capital Fund

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Regulatory bodies are taking a more stringent approach to excipient quality, but unlike guidance on GMP for APIs, those for excipients offer a framework only, meaning the onus lies with the manufacturer or supplier.


Regulating Excipient Quality, No Mean Feat

LBB Specialties and Meggle Excipients & Technology will work to distribute excipient products to companies in the American pharmaceutical and nutraceutical industries. 